Rezolute (RZLT) News Today $5.01 +0.06 (+1.21%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025?November 16, 2024 | msn.comRezolute’s Promising Growth: Buy Rating Backed by Financial and Clinical AdvancementsNovember 9, 2024 | markets.businessinsider.comPromising Developments and Strong Financial Position Justify Buy Rating for RezoluteNovember 9, 2024 | markets.businessinsider.comRezolute’s Promising Pipeline and Financial Stability Drive Buy Rating and Increased Price TargetNovember 9, 2024 | markets.businessinsider.comRezolute’s Strategic Progress and Financial Resilience Justify Buy RatingNovember 9, 2024 | markets.businessinsider.comRezolute (NASDAQ:RZLT) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $14.00 target price on shares of Rezolute in a report on Friday.November 8, 2024 | marketbeat.comRezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business UpdateNovember 8, 2024 | markets.businessinsider.comWedbush Predicts Rezolute's Q1 Earnings (NASDAQ:RZLT)Rezolute, Inc. (NASDAQ:RZLT - Free Report) - Stock analysts at Wedbush issued their Q1 2025 earnings per share estimates for shares of Rezolute in a report issued on Monday, November 4th. Wedbush analyst Y. Zhong anticipates that the company will post earnings per share of ($0.44) for the quarterNovember 7, 2024 | marketbeat.comWedbush Initiates Coverage of Rezolute (RZLT) with Outperform RecommendationNovember 6, 2024 | msn.comRezolute initiated with an Outperform at WedbushNovember 5, 2024 | markets.businessinsider.comRezolute (NASDAQ:RZLT) Given Outperform Rating at WedbushWedbush reissued an "outperform" rating and issued a $112.00 target price on shares of Rezolute in a research note on Monday.November 4, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Given Average Rating of "Buy" by BrokeragesShares of Rezolute, Inc. (NASDAQ:RZLT - Get Free Report) have earned a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the stock, Marketbeat reports. Seven analysts have rated the stock with a buy rating. The average 12 month price target among brokeragesNovember 1, 2024 | marketbeat.comWith 62% ownership, Rezolute, Inc. (NASDAQ:RZLT) boasts of strong institutional backingOctober 17, 2024 | finance.yahoo.comRezolute, Inc. (NASDAQ:RZLT) Stock Position Reduced by Renaissance Technologies LLCRenaissance Technologies LLC decreased its stake in Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 45.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 180,421 shares of the company's stock afOctober 8, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of "Buy" from AnalystsRezolute, Inc. (NASDAQ:RZLT - Get Free Report) has been given an average rating of "Buy" by the seven ratings firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that haveOctober 7, 2024 | marketbeat.comEdward Nash Recommends Buy on Rezolute, Sets $9 Target Amidst Product Progress and Regulatory AdvancementsOctober 5, 2024 | markets.businessinsider.comMarshall Wace LLP Acquires New Shares in Rezolute, Inc. (NASDAQ:RZLT)Marshall Wace LLP bought a new position in Rezolute, Inc. (NASDAQ:RZLT - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 1,047,230 shares of the company's stock, valued at approximately $4,503,000. MarshOctober 2, 2024 | marketbeat.comBuy Rating Affirmed for Rezolute on Strong Clinical Progress and Strategic Pipeline DevelopmentSeptember 28, 2024 | markets.businessinsider.comRezolute (NASDAQ:RZLT) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $14.00 target price on shares of Rezolute in a research note on Friday.September 27, 2024 | marketbeat.comAffinity Asset Advisors LLC Acquires 250,000 Shares of Rezolute, Inc. (NASDAQ:RZLT)Affinity Asset Advisors LLC lifted its holdings in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 15.6% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,850,000 shares of the company's stock after buying an additional 250,000September 25, 2024 | marketbeat.comInsider Buying: Rezolute, Inc. (NASDAQ:RZLT) Director Buys 4,259 Shares of StockSeptember 25, 2024 | insidertrades.comJMP Securities Reiterates "Market Outperform" Rating for Rezolute (NASDAQ:RZLT)JMP Securities restated a "market outperform" rating and issued a $7.00 target price on shares of Rezolute in a research report on Friday.September 20, 2024 | marketbeat.comRezolute, Inc.: Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business UpdateSeptember 20, 2024 | finanznachrichten.deRezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business UpdateSeptember 19, 2024 | globenewswire.comRezolute, Inc. (NASDAQ:RZLT) Shares Bought by Federated Hermes Inc.Federated Hermes Inc. lifted its holdings in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 11.1% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,279,327 shares of the company's stocSeptember 15, 2024 | marketbeat.comRezolute (NASDAQ:RZLT) Price Target Raised to $15.00 at BTIG ResearchBTIG Research lifted their price target on Rezolute from $13.00 to $15.00 and gave the stock a "buy" rating in a report on Tuesday.September 10, 2024 | marketbeat.comPeninsula drug maker plots late-stage clinical trial after FDA lifts delaySeptember 10, 2024 | bizjournals.comFDA Gives Green Signal To Rezolute's Genetic Disorder TreatmentSeptember 9, 2024 | benzinga.comRezolute’s RZ358 Advances: FDA Clearance and Positive Trial Outlook Justify Buy RatingSeptember 9, 2024 | markets.businessinsider.comRezolute Buy Rating Affirmed: RZ358 Clinical Advancements and Strong Market PotentialSeptember 9, 2024 | markets.businessinsider.comRezolute rises as FDA lifts clinical hold on hyperinsulinism therapySeptember 9, 2024 | msn.comRezolute's (RZLT) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $14.00 price target on shares of Rezolute in a report on Monday.September 9, 2024 | marketbeat.comUS FDA lifts partial clinical hold on Rezolute's blood sugar treatmentSeptember 9, 2024 | reuters.comFDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 StudySeptember 9, 2024 | globenewswire.comRezolute to Participate in Upcoming Investor ConferencesAugust 28, 2024 | markets.businessinsider.comGuggenheim Initiates Coverage of Rezolute (RZLT) with Buy RecommendationAugust 28, 2024 | msn.comRezolute (NASDAQ:RZLT) Coverage Initiated by Analysts at GuggenheimGuggenheim assumed coverage on Rezolute in a research note on Tuesday. They issued a "buy" rating and a $11.00 target price on the stock.August 27, 2024 | marketbeat.comVanguard Group Inc. Buys 145,700 Shares of Rezolute, Inc. (NASDAQ:RZLT)Vanguard Group Inc. increased its position in shares of Rezolute, Inc. (NASDAQ:RZLT - Free Report) by 10.4% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,553,352 shares of the company's stock after buyiAugust 19, 2024 | marketbeat.comRezolute, Inc. (NASDAQ:RZLT) Given Consensus Recommendation of "Buy" by BrokeragesShares of Rezolute, Inc. (NASDAQ:RZLT - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the firm, Marketbeat reports. Seven equities research analysts have rated the stock with a buy rating. The average 12-month priceAugust 18, 2024 | marketbeat.comBuy Rating Affirmed for Rezolute on Strong Phase 3 Progress and Positive Drug ProspectsAugust 8, 2024 | markets.businessinsider.comRezolute gets FDA okay for Phase 3 ersodetug registrational studyAugust 7, 2024 | msn.comBuy Rating Affirmed for Rezolute as RZ358 Advances Towards Phase 3 with FDA BackingAugust 7, 2024 | markets.businessinsider.comRZLT Aug 2024 7.500 callAugust 5, 2024 | ca.finance.yahoo.comRezolute Application for Hypoglycemia Treatment Gets FDA ClearanceAugust 5, 2024 | marketwatch.comRezolute Gets FDA Clearance For IND Application For RZ358 - Quick FactsAugust 5, 2024 | markets.businessinsider.comRezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor HyperinsulinismAugust 5, 2024 | globenewswire.comRezolute to Participate in the BTIG Virtual Biotechnology ConferenceJuly 31, 2024 | tmcnet.comBuy Rating for Rezolute: Strong Performance and Regulatory Progress as Key Growth DriversJuly 19, 2024 | markets.businessinsider.comBTIG Initiates Coverage of Rezolute (RZLT) with Buy RecommendationJuly 19, 2024 | msn.comRezolute, Inc. (NASDAQ:RZLT) Director Wladimir Hogenhuis Purchases 4,815 SharesJune 28, 2024 | insidertrades.com Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. RZLT Media Mentions By Week RZLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RZLT News Sentiment▼0.660.46▲Average Medical News Sentiment RZLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RZLT Articles This Week▼12▲RZLT Articles Average Week Get Rezolute News Delivered to You Automatically Sign up to receive the latest news and ratings for RZLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KALV News LFVN News XERS News ARDX News BCAX News APLT News AVDL News ZYME News SEPN News COGT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RZLT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rezolute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rezolute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.